Orders over $200 ship free on all productsResearch-use material
Metabolic & PerformanceCJC-1295 no DAC5mg
5.01 verified review$79
A short-acting GHRH analog studied for pulse-style growth-hormone and IGF-1 signaling.
For laboratory research use only. Not for human or animal consumption.
Research overview
CJC-1295 no DAC, often discussed as Modified GRF(1-29), is a short-acting analog of GHRH, the hypothalamic signal that prompts growth-hormone release. Without the Drug Affinity Complex used in the longer-acting DAC form, research interest centers on a brief GHRH signal rather than a prolonged exposure window.
Research centers on growth-hormone and downstream IGF-1 signaling while preserving a more pulse-style profile. It is commonly studied in growth-hormone-axis models, recovery and body-composition research, and models where a GHRH-plus-secretagogue signal is the research target.
Dedicated controlled data on the no-DAC variant remains limited, and much of the published CJC-1295 literature focuses on the DAC-bearing form. That keeps the no-DAC version investigational and distinct from approved therapies.
Storage quick reference
Protect from light. Keep all vials and bacteriostatic water away from direct sunlight and minimize other light exposure.
From the Curo library
Selected research
Reviews
5.01 verified reviewCJC-1295 came quick. I had trouble finding something on the COA at first so I called support and they explained it right away. Good people.